EMERGING MARKETS QUALITY TRIALS LIMITEDActive
Key figures
Like most small UK companies, EMERGING MARKETS QUALITY TRIALS LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2024/25Balance sheet structure
Filed accounts2020/21–2024/25
| 2020/21 | 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|---|
| Cash at bank and in hand | 98,489 | 161,735 | 74,268 | 31,581 | 33,769 |
| Total assets | 165,732 | 213,793 | 130,801 | 73,499 | 127,393 |
| Total liabilities | — | — | 46,252 | — | — |
| Net assets / total equity | 113,425 | 168,217 | 84,395 | 31,676 | 54,662 |
| Average number of employees | 4 | 4 | 4 | 3 | 0 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: EMERGING MARKETS QUALITY TRIALS LIMITED
Company
EMERGING MARKETS QUALITY TRIALS LIMITED is a private limited company registered with Companies House under company number 12909095. It was incorporated on 28 Sep 2020. Its status is active. The registered office is in Milton keynes (MK11). Its nature of business (SIC 2007) is information technology consultancy activities (62020), other information technology service activities (62090), management consultancy activities other than financial management (70229), research and experimental development on biotechnology (72110).
Accounts
The latest accounts in the database are for 2024/25 (period ending 30 Sep 2025); the company files small company accounts (filleted). Net assets were £54,662, up 72.6% on the previous year. Cash at bank and in hand was £33,769. The company had an average of 0 employees. Figures are available for 5 financial years (2020/21–2024/25).
Control and charges
2 persons with significant control are registered.
Filing deadlines
The next accounts are due by 30 Jun 2027. The next confirmation statement is due by 26 Aug 2027.